ABM · healthcare · North AmericaJul 202611 min read358 words

The account-based marketing framework we install for every client for healthcare and life sciences in North America

A repeatable, seven-part framework for running account-based marketing as a system — the same one we use inside every Growth Broker engagement. Written for commercial leaders at healthtech, medtech, and life-sciences companies in North America.

This edition of the Growth Broker playbook is written for commercial leaders at healthtech, medtech, and life-sciences companies operating in North America. In this market, the North American B2B buyer is saturated with vendor outreach and rewards specificity, category clarity, and speed, so the way you install account-based marketing has to be shaped to that reality from day one.

We have installed account-based marketing inside more than fifty companies. This is the framework we reach for every time. Account-based marketing is concentrating marketing on a named list of accounts with tailored plays, and the framework exists to keep that definition honest under real conditions.

Part one, diagnosis. Before you touch the model, name the constraint: finance, demand, access, or conversion. Account-based marketing applied to the wrong constraint is theatre.

Part two, target. Narrow to one industry, one role, one trigger. Every extra dimension halves conversion.

Inside healthcare and life sciences, the binding constraint is almost always regulated-sale cycle length, not intent, and in North America it is compounded by the fact that signal above noise, not lead volume is what actually gates growth. Account-based marketing is only useful here when it is pointed at both constraints at once.

Part three, offer. What is the buyer's next step, and what makes it obvious? The offer, not the copy, is what carries.

Part four, engine. Tools, sequences, data. Buy the minimum you can operate; every extra tool is a future dependency.

Part five, operating rhythm. Monday plan, Friday review, weekly pipeline created inside the named-account list. Nothing about the model is left to memory.

Parts six and seven, learning and allocation. What did we learn last week; where does next week's dollar go. Once those two loops are live, account-based marketing compounds and the framework stops being visible.

Concretely for healthcare and life sciences in North America: the healthcare teams that install this get past procurement instead of dying in it, and the North American teams that install this land inside the first quarter, not the fourth. That is the reason it is worth installing account-based marketing deliberately for this market rather than importing a playbook designed for somewhere else.

ABMaccount based marketing1:1 ABMABM frameworkABM modelABM for healthcare and life sciencesABM in North Americahealthcare and life sciences growth in North America

Frequently asked questions

ABM · healthcare · North America — answered

Does account-based marketing work for healthcare and life sciences in North America?
Yes — provided it is pointed at regulated-sale cycle length, not intent and adapted to the fact that in North America, the North American B2B buyer is saturated with vendor outreach and rewards specificity, category clarity, and speed. The healthcare teams that install this get past procurement instead of dying in it.
Do I need all seven parts to see results?
Diagnosis, target, and operating rhythm are the non-negotiables. The others can lag by weeks, not quarters.
How long does the framework take to install?
Six to twelve weeks depending on the state of the data and the size of the team.
Can I adapt the framework to my stack?
The framework is stack-agnostic. Tooling is part four and is the most swappable piece.
What is the biggest risk to the framework?
Confusing ABM with lead scoring on inbound MQLs — usually because a stakeholder shortcuts diagnosis to get to spend.
What is the North America-specific pitfall when running account-based marketing for healthcare?
Importing a playbook that was built for another market. In North America, the North American B2B buyer is saturated with vendor outreach and rewards specificity, category clarity, and speed — the install has to reflect that.

Growth Broker editorial

Filed under abm · healthcare · north america

Up next

AI for Growth: the complete 2026 guide for B2B companies

Read piece

Ready to broker your growth?

Book a Growth Call